Skip to main content
Fig. 2 | Eye and Vision

Fig. 2

From: Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography

Fig. 2

Different response to different types of anti-VEGF patients. a–f A 76-year-old male type 2 patient showing good response. Greatest vascular caliber (GVC) was 94.06 μm at baseline and decreased to 89.66 μm after three monthly anti-VEGF treatment; g–l A 75-year-old male type 1 patient demonstrating poor response. GVC was 72.08 μm at baseline and increased to 102.05 μm after three monthly anti-VEGF treatment

Back to article page

Eye and Vision

ISSN: 2326-0254